Your browser is no longer supported. Please, upgrade your browser.
ANAB AnaptysBio, Inc. daily Stock Chart
ANAB [NASD]
AnaptysBio, Inc.
Index- P/E- EPS (ttm)-3.60 Insider Own0.40% Shs Outstand26.11M Perf Week0.71%
Market Cap368.15M Forward P/E- EPS next Y-3.02 Insider Trans3.57% Shs Float25.83M Perf Month-23.45%
Income-97.30M PEG- EPS next Q-0.63 Inst Own- Short Float23.09% Perf Quarter-6.62%
Sales8.00M P/S46.02 EPS this Y-43.90% Inst Trans2.44% Short Ratio9.64 Perf Half Y-58.60%
Book/sh14.91 P/B0.95 EPS next Y-19.80% ROA-20.90% Target Price18.00 Perf Year-82.24%
Cash/sh14.33 P/C0.98 EPS next 5Y- ROE-22.30% 52W Range10.00 - 83.10 Perf YTD-13.23%
Dividend- P/FCF- EPS past 5Y- ROI-26.40% 52W High-83.03% Beta-
Dividend %- Quick Ratio12.80 Sales past 5Y-12.80% Gross Margin- 52W Low41.00% ATR1.30
Employees89 Current Ratio12.80 Sales Q/Q- Oper. Margin- RSI (14)47.58 Volatility7.28% 9.94%
OptionableYes Debt/Eq0.00 EPS Q/Q-17.70% Profit Margin- Rel Volume1.02 Prev Close13.50
ShortableYes LT Debt/Eq0.00 EarningsMar 12 BMO Payout- Avg Volume618.98K Price14.10
Recom3.00 SMA20-1.18% SMA50-6.33% SMA200-52.94% Volume632,567 Change4.44%
Nov-08-19Downgrade Wedbush Outperform → Neutral
Nov-08-19Downgrade SunTrust Buy → Hold
Nov-08-19Downgrade JP Morgan Overweight → Underweight $109 → $17
Nov-08-19Downgrade Jefferies Buy → Hold $12
Jun-21-19Downgrade Stifel Buy → Hold $124 → $74
Jun-21-19Downgrade Credit Suisse Outperform → Neutral $137 → $79
Dec-20-18Initiated H.C. Wainwright Buy $126
Nov-21-18Initiated JP Morgan Overweight $115
Jul-19-18Initiated Credit Suisse Outperform $104
Apr-04-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Mar-27-18Reiterated Stifel Buy $139 → $152
Mar-06-18Reiterated Stifel Buy $130 → $139
Feb-15-18Reiterated SunTrust Buy $115 → $162
Jan-23-18Reiterated Credit Suisse Outperform $85 → $135
Nov-15-17Initiated SunTrust Buy $115
Nov-09-17Initiated Jefferies Buy $101
Oct-11-17Reiterated RBC Capital Mkts Outperform $40 → $79
Sep-15-17Initiated RBC Capital Mkts Outperform $40
Jul-11-17Initiated Robert W. Baird Outperform $36
Feb-21-17Initiated Wedbush Outperform $28
Apr-05-20 06:15PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:47PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WWE, AAN and ANAB ACCESSWIRE
Apr-03-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANAB, SIX INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
05:15PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Application Deadline Approaching ACCESSWIRE
03:45PM  SHAREHOLDER ALERT: LK TLRY ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:55PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:30PM  CLASS ACTION UPDATE for LK, TLRY and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:45AM  AnaptysBio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In AnaptysBio, Inc. To Contact The Firm Newsfile
10:32AM  ANAB INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:00AM  CLASS ACTION UPDATE for WWE, CRON and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Apr-02-20 08:44PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Important Deadlines Established GlobeNewswire
12:30PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:45AM  SHAREHOLDER ALERT: MGPI ANAB VMW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:00AM  ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Apr-01-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ANAB, SSL, XP INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire -5.87%
08:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exela Technologies, RTI Surgical, DouYu, and AnaptysBio and Encourages Investors to Contact the Firm GlobeNewswire
06:23PM  ANAPTYSBIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for Southern District of California against AnaptysBio, Inc. GlobeNewswire
12:30PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:45AM  CLASS ACTION UPDATE for TUP, BDX and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:31AM  ANAB INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:52AM  AnaptysBio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AnaptysBio, Inc. To Contact The Firm Newsfile
Mar-31-20 08:04PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Important Deadlines Established ACCESSWIRE
07:15PM  ANAB Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against AnaptysBio, Inc. (NASDAQ: ANAB); Lead Plaintiff Deadline is May 26, 2020 PR Newswire
07:00PM  ANAPTYSBIO SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB Business Wire
02:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WWE, ANAB and HAFC ACCESSWIRE
01:10PM  ONE STOCK SYMBOL INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INO, ANAB and HAFC ACCESSWIRE
11:15AM  ANAB LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc.; Encourages Investors with Large Losses to Contact Firm ANAB GlobeNewswire
10:45AM  CLASS ACTION UPDATE for CRON, ANAB and HAFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:00AM  ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
Mar-30-20 11:01PM  ANAPTYSBIO DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in AnaptysBio, Inc. to Contact the Firm Business Wire
10:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCI, ALGN and ANAB ACCESSWIRE
08:10PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed ACCESSWIRE
03:35PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SSL, ANAB and HAFC ACCESSWIRE
03:00PM  ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
01:50PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:05PM  SHAREHOLDER ALERT: SSL JELD ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:00PM  All You Need to Know About AnaptysBio, Inc. (ANAB) Rating Upgrade to Buy Zacks
11:02AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB GlobeNewswire
10:30AM  ANAB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Mar-29-20 10:25AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HPQ, CAN and ANAB ACCESSWIRE
Mar-28-20 02:00PM  IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Mar-27-20 07:45PM  ANAB ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc. - ANAB PR Newswire
05:00PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of AnaptysBio, Inc. (ANAB) Investors Business Wire
04:25PM  AnaptysBio Investor Alert: Class Action Lawsuit Filed ACCESSWIRE
04:14PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed GlobeNewswire
03:00PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf AnaptysBio, Inc. (ANAB) Investors Business Wire
02:45PM  SHAREHOLDER ALERT: CCI TLRY ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
02:03PM  Shareholder Alert: Robbins LLP Announces AnaptysBio, Inc. (ANAB) Sued for Misleading Shareholders Business Wire
01:15PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WBK, CCI and ANAB ACCESSWIRE
12:00PM  The Law Offices of Frank R. Cruz Announces Investigation on Behalf of AnaptysBio Inc. Investors (ANAB) Business Wire
11:39AM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AnaptysBio, Inc. (ANAB) GlobeNewswire
10:00AM  ANAB Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AnaptysBio, Inc. and Encourages Investors to Contact the Firm PR Newswire
09:45AM  CLASS ACTION UPDATE for WWE, AAN and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:00AM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
07:46AM  AnaptysBio (ANAB) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm GlobeNewswire
Mar-26-20 09:21PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed PR Newswire
06:39PM  ANAPTYSBIO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AnaptysBio, Inc. and Encourages Investors to Contact the Firm Business Wire
06:30PM  Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AnaptysBio, Inc. (ANAB) on Behalf of Investors Business Wire
04:44PM  AnaptysBio (ANAB) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm PR Newswire
04:40PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AnaptysBio, Inc. (ANAB) on Behalf of Investors Business Wire
03:15PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:08PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:10PM  ANAB Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AnaptysBio, Inc. and Encourages Investors to Contact the Firm ACCESSWIRE
10:49AM  ANAB Stock - Class Action Lawsuit Filed Against AnaptysBio, Inc. on Behalf of Purchasers or Acquirers of ANAB Stock Between October 10, 2017 and November 7, 2019, Both Dates Inclusive - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of AnaptysBio, Inc. Investors PR Newswire
10:04AM  Have Insiders Been Buying AnaptysBio, Inc. (NASDAQ:ANAB) Shares? Simply Wall St.
09:22AM  EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc. ANAB Business Wire
09:00AM  ANAPTYSBIO SHAREHOLDER ALERT: Class Action Lawsuit Filed ACCESSWIRE
Mar-25-20 08:55PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
05:02PM  Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc. PR Newswire
Mar-02-20 08:45AM  AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline Updates GlobeNewswire +15.12%
Feb-25-20 04:00PM  AnaptysBio to Present at The Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Feb-09-20 09:30AM  Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly? Simply Wall St.
Feb-03-20 11:27AM  Andreas Halvorsen Trims Adaptive Biotechnologies Stake GuruFocus.com
Jan-08-20 04:00PM  AnaptysBio to Present at J.P. Morgan Annual Healthcare Conference GlobeNewswire
Jan-06-20 12:00PM  What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock Zacks
Dec-19-19 06:17AM  What Kind Of Share Price Volatility Should You Expect For AnaptysBio, Inc. (NASDAQ:ANAB)? Simply Wall St.
Dec-13-19 10:01AM  Hedge Funds Couldnt Dump AnaptysBio, Inc. (ANAB) Fast Enough Insider Monkey
Nov-24-19 04:18PM  Analysts See These 2 Falling Knives Rebounding Within a Year GuruFocus.com
Nov-11-19 10:53AM  These Are The Winners Of The Inaugural WeTrader Paper Trading Competition Benzinga
08:55AM  AnaptysBio Enters Oversold Territory Zacks
Nov-08-19 04:21PM  Why This Biotech Stock Just Crashed 72% To Its Lowest-Ever Point Investor's Business Daily -71.85%
10:18AM  Short Seller Scores Big Win as Tiny Biotech Stock Sinks 72% Bloomberg
09:25AM  AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Lags Revenue Estimates Zacks
08:53AM  Benzinga Pro's Top 5 Stocks To Watch For Fri., Nov. 8, 2019: DIS, STMP, ANAB, GDOT, MCD Benzinga
08:05AM  AnaptysBio Announces Third Quarter 2019 Financial Results and Provides Pipeline Updates GlobeNewswire
08:00AM  AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary Endpoint GlobeNewswire
Nov-07-19 10:30AM  Earnings Preview: AnaptysBio, Inc. (ANAB) Q3 Earnings Expected to Decline Zacks
Oct-31-19 11:06AM  Top Ranked Momentum Stocks to Buy for October 31st Zacks
Oct-26-19 12:44PM  Here is What Hedge Funds Think About AnaptysBio, Inc. (ANAB) Insider Monkey
Oct-20-19 08:15AM  Did Changing Sentiment Drive AnaptysBio's (NASDAQ:ANAB) Share Price Down A Worrying 53%? Simply Wall St.
Oct-03-19 08:39AM  AnaptysBio (ANAB) Looks Good: Stock Adds 8.1% in Session Zacks
Oct-02-19 07:17AM  The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data Benzinga +8.10%
Oct-01-19 04:10PM  Investors Yawn As Biotech Puts Up Positive Test Results For 2 Patients Investor's Business Daily -10.40%
02:53PM  Wedbush: Investors Largely Underappreciating AnaptysBio Benzinga
11:18AM  AnaptysBio Shares Drop Amid Questions About Phase II Participation Numbers TheStreet.com
Sep-30-19 04:15PM  AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis GlobeNewswire
Sep-27-19 06:30AM  AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Aug-21-19 10:48AM  Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly? Simply Wall St.
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's products include Etokimab, an anti-interleukin (IL)-33 program for the treatment of atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps; ANB019, an anti-IL-36 receptor program for generalized pustular psoriasis and palmo-plantar pustular psoriasis; and anti-inflammatory checkpoint modulators for inflammatory diseases. It is also developing immuno-oncology products, including TSR-042: anti-PD-1, TSR-022: anti-TIM-3, TSR-033: anti-LAG-3, and TSR-075: anti-PD-1/LAG-3 bispecific; and CC-90006: anti-PD-1 agonist for psoriasis, as well as other products for inflammation. AnaptysBio, Inc. has an immuno-oncology partnership with TESARO, Inc. and TESARO Development, Ltd., including an anti-PD-1 antagonist antibody (TSR-042), an anti-TIM-3 antagonist antibody (TSR-022), and an anti-LAG-3 antagonist antibody (TSR-033); and an inflammation partnership with Celgene Corporation, including an anti-PD-1 checkpoint agonist antibody (CC-90006) in clinical development. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was founded in 2005 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Suria HamzaPresident, CEOMar 10Option Exercise1.1210,00011,20047,636Mar 10 05:02 PM
Suria HamzaPresident, CEOFeb 05Option Exercise1.1210,00011,20037,636Feb 06 05:46 PM
Ware J. AnthonyDirectorDec 10Buy14.053,60050,5803,600Feb 06 05:48 PM
Londei MarcoChief Medical OfficerNov 27Option Exercise6.9346,202320,18068,579Dec 02 04:29 PM
Suria HamzaPresident, CEONov 22Option Exercise1.1210,00011,20027,636Nov 25 04:49 PM
Suria HamzaPresident, CEOJun 10Sale73.7622,4281,654,35017,636Jun 12 05:00 PM
Londei MarcoChief Medical OfficerJun 04Option Exercise0.7010,0607,04232,437Jun 05 05:54 PM
Londei MarcoChief Medical OfficerJun 04Sale73.0610,060734,96222,377Jun 05 05:54 PM
Suria HamzaPresident, CEOApr 17Option Exercise1.1210,00011,20040,064Apr 18 06:34 PM